Viewing Study NCT01537250


Ignite Creation Date: 2025-12-24 @ 4:46 PM
Ignite Modification Date: 2026-02-25 @ 6:30 PM
Study NCT ID: NCT01537250
Status: COMPLETED
Last Update Posted: 2018-01-24
First Post: 2012-02-05
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase II Clinical Study to Assess the Efficacy and Safety of Nemonoxacin Malate in Treating Adult Patients With Community-acquired Pneumonia (CAP)
Sponsor: TaiGen Biotechnology Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module